Literature DB >> 1993696

Comparison of the physicochemical properties of type I and type II iodothyronine 5'-deiodinase.

M Safran1, J L Leonard.   

Abstract

The 5'-deiodination of thyroxine is catalyzed by two enzymes which differ in their tissue distribution, substrate specificities, sensitivity to the inhibitor, propylthiouracil, and response to thyroid status. By using the affinity label, N-bromoacetyl-L-thyroxine, both isoenzymes have been found to have substrate binding subunits of approximately 27 kDa. In this study, we compared the substrate binding subunits and hydrodynamic properties of the type I and the type II isozymes using the affinity label, N-bromoacetyl-L-thyroxine, to identify the enzymes. High resolution sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that the substrate binding subunit of the type I enzyme had an Mr of 27,000, while that of the type II enzyme had a slightly higher Mr of 29,000. This difference was not accounted for by glycosylation. Partial staphylococcal V8-protease digests of the substrate binding subunit of the type I enzyme yielded fragments of 14.6, 13.7, and 7.0 kDa, while V8-protease digests of the substrate binding subunit for the type II enzyme produced fragments of 28.0, 25.1, 19.0, 9.5, 7.2, and 5.8 kDa. Unique cyanogen bromide fragmentation patterns were also observed for the two substrate binding subunits. Sedimentation coefficients of the detergent-soluble type I and type II holoenzymes were 3.67 and 5.22 S, respectively, as determined by sucrose density centrifugation. The type I enzyme behaved as a globular protein, whereas the type II enzyme showed sedimentation properties typical of asymmetric integral membrane proteins. The Stokes radii were 3.78 and 4.97 nm, respectively. From these data, the calculated Mr for detergent-solubilized type I 5'-iodothyronine deiodinase was 55,400 and for the type II enzyme was 198,700. These data indicate that the two isozymes of iodothyronine 5'-deiodinase are multimeric, differ in holoenzyme size and subunit composition, and that their substrate binding subunits are distinct.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993696

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  The thyroid hormone-inactivating deiodinase functions as a homodimer.

Authors:  G D Vivek Sagar; Balázs Gereben; Isabelle Callebaut; Jean-Paul Mornon; Anikó Zeöld; Cyntia Curcio-Morelli; John W Harney; Cristina Luongo; Michelle A Mulcahey; P Reed Larsen; Stephen A Huang; Antonio C Bianco
Journal:  Mol Endocrinol       Date:  2008-03-20

Review 2.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

Review 3.  Type 2 deiodinase at the crossroads of thyroid hormone action.

Authors:  Rafael Arrojo E Drigo; Antonio C Bianco
Journal:  Int J Biochem Cell Biol       Date:  2011-06-12       Impact factor: 5.085

4.  Adrenal gland 5'deiodinase activity (AG-5'd). Kinetic characterization and fractional turnover rate (FTr).

Authors:  M Luna; B Anguiano; C Valverde-R
Journal:  Endocrine       Date:  1995-05       Impact factor: 3.633

5.  Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues.

Authors:  W Croteau; J C Davey; V A Galton; D L St Germain
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  Type I 5'-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma.

Authors:  J Pachucki; M Ambroziak; Z Tanski; J Luczak; J Nauman; A Nauman
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

7.  Differential selenium-dependent expression of type I 5'-deiodinase and glutathione peroxidase in the porcine epithelial kidney cell line LLC-PK1.

Authors:  M Gross; M Oertel; J Köhrle
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.